Catalyst
Slingshot members are tracking this event:
Enrollment in VX-661 in combination with ivacaftor in people with gating mutations is expected to complete in late 2016 or early 2017
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| VRTX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 08, 2017
Occurred Source:
http://investors.vrtx.com/releasedetail.cfm?ReleaseID=1006996
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Gating Defect, Cftr Protein, Second Mutation, F508del Mutation
